Pattern Speaker

The iOPEN logo
AAO Industry Insights Report
is available now!

Download the redacted report here

To download the redacted AAO Industry Insights Report please complete the form below:

* indicates required

Please select all the ways you would like to hear from Fishawack Group of Companies:

You can unsubscribe at any time by clicking the link in the footer of our emails. For information about our privacy practices, please visit our website.

We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

AAO 2019 marked a pivotal moment in the retinal space. Data were presented to accompany the long-awaited launch of brolucizumab, while important interim data supporting abicipar, risuteganib, ranibizumab PDS, faricimab, and aflibercept were shared with all the attending delegates.

During AAO, iOPEN conducted a pilot program utilizing the power of the QROWD (Quick Responses of Worldwide Doctors) to obtain validated and targeted customer opinions on key data presented during the congress. Our QROWD experts comprise a representative group of target clinicians from differing locations and with differing levels of experience. For AAO, this team of top-tier, mid-tier, and ground-level experts provided instant, independent answers to key questions on the presented data. The responses were collated and analyzed by our three core faculty members.

The US retina market is now more complex than ever, and constantly evolving competitor landscapes mean the evidence base and commercial positioning you need today may be considered outdated and redundant by tomorrow. This is where the iOPEN AAO Industry Insights Report can help.

Scroll up button

Unique top level insights

The comprehensive iOPEN AAO Industry Insights Report uniquely offers top-level insights on the pivotal presented AAO data from our world-renowned core iOPEN faculty; Tarek Hassan, Carl Awh, and David Chow; together with honest crowdsourced opinions independently collated from a wide cross-section of retina specialists using our landmark proprietary QROWD platform.

Photo of Tarek Hassan

Tarek Hassan

Photo of Carl Awh

Carl Awh

Photo of David Chow

David Chow

Please complete this form to download the redacted AAO Industry Insights Report

Professional insights
from our expert faculty

The iOPEN AAO Industry Insights Report can help you discover what retina specialists really think about the data you and your competitors presented at AAO. Together with the summaries provided by our expert faculty, you can also find out WHY retina specialists hold these opinions. We can help you answer questions such as:

  • In which subpopulations of patients and at what stage are pipeline retinal therapies like brolucizumab, abicipar, risuteganib, ranibizumab PDS, and faricimab most likely to be used?
  • Why do your potential customers currently think this way?
  • Which of the pipeline data presented at AAO were considered most impressive and why?
  • Which company’s commercial booth stood out most?
  • What were the reasons for this?
Scroll up button

To find out more about how you can receive an UNREDACTED version of the iOPEN AAO Industry Insights Report, please contact